Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 20;10(10):CD011537.
doi: 10.1002/14651858.CD011537.pub3.

Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction

Laurentiu Craciunas  1 , Nikolaos Tsampras, Nick Raine-Fenning, Arri Coomarasamy
Affiliations
Review

Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction

Laurentiu Craciunas et al. Cochrane Database Syst Rev. .

Abstract

Background: Most women undergoing assisted reproduction treatment will reach the stage of embryo transfer (ET), but the proportion of embryos that can be successfully implanted after ET has remained small since the mid-1990s. Human chorionic gonadotropin (hCG) is a hormone that is synthesised and released by the syncytiotrophoblast and has a fundamental role in embryo implantation and the early stages of pregnancy. Intrauterine administration of hCG via ET catheter during a mock procedure around the time of ET is a novel approach that has been suggested to improve the outcomes of assisted reproduction.

Objectives: To investigate whether intrauterine (intracavity) administration of hCG (IC-hCG) around the time of ET improves clinical outcomes in subfertile women undergoing assisted reproduction.

Search methods: We performed searches on 9 January 2018 using Cochrane methods.

Selection criteria: We looked for randomised controlled trials (RCTs) evaluating IC-hCG around the time of ET, irrespective of language and country of origin.

Data collection and analysis: Two review authors independently selected studies, assessed risk of bias, extracted data from studies, and attempted to contact study authors when data were missing. We performed statistical analysis using Review Manager 5. We assessed evidence quality using GRADE methods. Primary outcomes were live birth and miscarriage; secondary outcomes were clinical pregnancy rate and complications.

Main results: Seventeen RCTs investigated the effects of IC-hCG administration for 4751 subfertile women undergoing assisted reproduction. IC-hCG was administered in variable doses at different times before the ET. hCG was obtained from the urine of pregnant women or from cell cultures using recombinant DNA technology.Most studies (12/17) were at high risk of bias in at least one of the seven domains assessed. Common problems were unclear reporting of study methods and lack of blinding. The main limitations for evidence quality were high risk of bias and serious imprecision.For analyses of live birth and clinical pregnancy, there was considerable heterogeneity (I² > 75%) and therefore we present subgroups for dosage and stage of ET. Exploration for sources of heterogeneity revealed two key prespecified variables as important determinants: stage of ET (cleavage vs blastocyst stage) and dose of IC-hCG (< 500 international units (IU) vs ≥ 500 IU). We performed meta-analyses within subgroups defined by stage of embryo and dose of IC-hCG.Live birth rates among women having cleavage-stage ET with an IC-hCG dose < 500 IU compared to women having cleavage-stage ET without IC-hCG showed no benefit of the intervention and would be consistent with no substantive difference or disadvantage of indeterminate magnitude (risk ratio (RR) 0.76, 95% confidence interval (CI) 0.58 to 1.01; one RCT; 280 participants; I² = 0%; very low-quality evidence). In a clinic with a live birth rate of 49% per cycle, use of IC-hCG < 500 IU would be associated with a live birth rate ranging from 28% to 50%.Results show an increase in live birth rate in the subgroup of women undergoing cleavage-stage ET with an IC-hCG dose ≥ 500 IU compared to women having cleavage-stage ET without IC-hCG (RR 1.57, 95% CI 1.32 to 1.87; three RCTs; 914 participants; I² = 0%; moderate-quality evidence). At a clinic with a live birth rate of 27% per cycle, use of IC-hCG ≥ 500 IU would be associated with a live birth rate ranging from 36% to 51%.Results show no substantive differences in live birth among women having blastocyst-stage ET with an IC-hCG dose ≥ 500 IU compared to women having blastocyst-stage ET without IC-hCG (RR 0.92, 95% CI 0.80 to 1.04; two RCTs; 1666 participants; I² = 0%; moderate-quality evidence). At a clinic with a live birth rate of 36% per cycle, use of IC-hCG ≥ 500 IU would be associated with a live birth rate ranging from 29% to 38%.Evidence for clinical pregnancy among women having cleavage-stage ET with an IC-hCG dose < 500 IU showed no benefit of the intervention and would be consistent with no substantive difference or disadvantage of indeterminate magnitude (RR 0.88, 95% CI 0.70 to 1.10; one RCT; 280 participants; I² = 0%; very low-quality evidence).Results show an increase in clinical pregnancy rate in the subgroup of women having cleavage-stage ET with an IC-hCG dose ≥ 500 IU compared to women having cleavage-stage ET without IC-hCG (RR 1.49, 95% CI 1.32 to 1.68; 12 RCTs; 2186 participants; I² = 18%; moderate-quality evidence).Results show no substantive differences in clinical pregnancy among women having blastocyst-stage ET with an IC-hCG dose ≥ 500 IU (RR 0.99, 95% CI 0.85 to 1.15; four RCTs; 2091 participants; I² = 42%; moderate-quality evidence) compared to women having blastocyst-stage ET with no IC-hCG.No RCTs investigated blastocyst-stage ET with an IC-hCG dose < 500 IU.We are uncertain whether miscarriage was influenced by intrauterine hCG administration (RR 1.04, 95% CI 0.81 to 1.35; 11 RCTs; 3927 participants; I² = 0%; very low-quality evidence).Reported complications were ectopic pregnancy (four RCTs; 1073 participants; four events overall), heterotopic pregnancy (one RCT; 495 participants; one event), intrauterine death (three RCTs; 1078 participants; 22 events), and triplets (one RCT; 48 participants; three events). Events were few, and very low-quality evidence was insufficient to permit conclusions to be drawn.

Authors' conclusions: There is moderate quality evidence that women undergoing cleavage-stage transfer using an IC-hCG dose ≥ 500 IU have an improved live birth rate. There is insufficient evidence for IC-hCG treatment for blastocyst transfer. There should be further trials with live birth as the primary outcome to identify the groups of women who would benefit the most from this intervention. There was no evidence that miscarriage was reduced following IC-hCG administration, irrespective of embryo stage at transfer or dose of IC-hCG. Events were too few to allow conclusions to be drawn with regard to other complications.

PubMed Disclaimer

Conflict of interest statement

LC, NT and AC do not have any conflicts of interest to disclose. NRF has received travel costs or advisory board honoraria from GE Healthcare, Merck Serono and Ferring and provides medico‐legal reports for court proceedings. He has shares in two fertility clinics.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
4
4
Funnel plot of comparison: 1 Intrauterine human chorionic gonadotropin (hCG) versus no hCG, outcome: 1.4 Clinical pregnancy.
5
5
Forest plot of comparison: 1 Intrauterine human chorionic gonadotropin (hCG) versus no hCG, outcome: 1.1 Live birth.
6
6
Forest plot of comparison: 1 Intrauterine human chorionic gonadotropin (hCG) versus no hCG, outcome: 1.2 Miscarriage.
7
7
Forest plot of comparison: 1 Intrauterine human chorionic gonadotropin (hCG) versus no hCG, outcome: 1.4 Clinical pregnancy.
8
8
Forest plot of comparison: 1 Intrauterine human chorionic gonadotropin (hCG) versus no hCG, outcome: 1.5 Complications.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Aaleyasin 2015 {published data only}
    1. Aaleyasin A, Aghahosseini M, Rashidi M, Safdarian L, Sarvi F, Najmi Z, et al. In vitro fertilization outcome following embryo transfer with or without preinstillation of human chorionic gonadotropin into the uterine cavity: a randomized controlled trial. Gynecologic and Obstetric Investigation 2015;79(3):201‐5. [DOI: 10.1159/000363235; PUBMED: 25531413] - DOI - PubMed
Cambiaghi 2013 {published data only}
    1. Cambiaghi AS, Leao RBF, Alvarez AV, Nascimento PF. Intrauterine injection of human chorionic gonadotropin before embryo transfer may improve clinical pregnancy and implantation rates in blastocysts transfers. Fertility and Sterility 2013;100(3):S121. [DOI: 10.1016/j.fertnstert.2013.07.1634] - DOI
Dehghani Firouzabadi 2016 {published data only}
    1. Dehghani Firouzabadi R, Janati, Razi MH. The effect of intrauterine human chorionic gonadotropin injection before embryo transfer on the implantation and pregnancy rate in infertile patients: a randomized clinical trial. International Journal of Reproductive Biomedicine 2016;14(10):657‐64. [PUBMED: 27921090] - PMC - PubMed
    1. Janati S, Dehghani Firouzabadi R, Mohseni F, Razi MH. Evaluation effect of intrauterine human chorionic gonadotropin injection before embryo transfer in implantation and pregnancy rate in infertile patients and comparison with conventional embryo transfer in IVF/ICSI/ET cycles. Iranian Journal of Reproductive Medicine 2013;11(4):67‐8.
Eskandar 2016 {published and unpublished data}
    1. Eskandar MA, Al‐Emain MA, Atwan YL, Bakar SD. Does intrauterine injection of human chorionic gonadotropin before embryo transfer improve the pregnancy rate in in vitro fertilization/intracytoplasmic sperm injection (IVFICSI) cycles? A prospective randomized controlled trial. Reproductive Sciences 2016;23(1 Suppl):102.
Hong 2014 {published data only}
    1. Hong KH, Forman EJ, Werner MD, Upham KM, Gumeny CL, Winslow AD, et al. Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized, double‐blind, placebo‐controlled trial. Fertility and Sterility 2014;102(6):1591‐5. [DOI: 10.1016/j.fertnstert.2014.08.006; PUBMED: 25234040] - DOI - PubMed
Hosseini 2016 {published data only}
    1. Hosseini RS, Farzadi L, Abdollahi S, Nouri M, Ghasemzadeh A, Hamdi K, et al. Effect of intrauterine injection of human chorionic gonadotropin before frozen‐thawed embryo transfer on implantation and clinical pregnancy rate: a randomized controlled trial. International Journal of Women’s Health and Reproduction Sciences 2016;4(4):189‐93. [DOI: 10.15296/ijwhr.2016.42] - DOI
Huang 2016 {published data only}
    1. Huang P, Wei L, Li X. A study of intrauterine infusion of human chorionic gonadotropin (hCG) before frozen‐thawed embryo transfer after two or more implantation failures. Gynecological Endocrinology 2017;33(1):67‐9. [DOI: 10.1080/09513590.2016.1207164; PUBMED: 27449969] - DOI - PubMed
Kokkali 2014 {published data only}
    1. Kokkali G, Chronopoulou M, Baxevani E, Biba M, Aggeli I, Fakiridou M, et al. A randomised control pilot study of the use of intrauterine human chorionic gonadotropin injection before embryo transfer in egg recipient cycles. Human Reproduction 2014;29(Suppl 1):i208.
Leao 2013 {published data only}
    1. Leao RBF, Cambiaghi AS, Leao BF, Alvarez ABV, Figueiredo PN. Intrauterine injection of human chorionic gonadotropin before embryo transfer may improve the pregnancy rates in in vitro fertilization cycles of patients with repeated implantation failures. Proceedings of the 5th IVI International Congress; 2013 Apr 4‐6; Seville, Spain. http://www.comtecmed.com/ivi/2013/Uploads/Editor/abstract_66.pdf. 2013. [http://comtecmed.com/ivi/2013/Uploads/Editor/abstract_66.pdf]
Mansour 2011 {published and unpublished data}
    1. Mansour R. Re: Intrauterine hCG [personal communication]. Email to: L Craciunas 10 June 2015.
    1. Mansour R, Tawab N, Kamal O, El‐Faissal Y, Serour A, Aboulghar M, et al. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertility and Sterility 2011;96(6):1370‐4. [DOI: 10.1016/j.fertnstert.2011.09.044; PUBMED: 22047664] - DOI - PubMed
Mostajeran 2017 {published data only}
    1. Mostajeran F, Godazandeh F, Ahmadi SM, Movahedi M, Jabalamelian SA. Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on pregnancy rate: a prospective randomized study. Journal of Research in Medical Sciences 2017;22:6. [DOI: 10.4103/1735-1995.199096; PUBMED: 28400828] - DOI - PMC - PubMed
Navali 2016 {published data only}
    1. Navali N, Gassemzadeh A, Farzadi L, Abdollahi S, Nouri M, Hamdi K, et al. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial. Human Reproduction 2016;31(11):2520‐6. [DOI: ; PUBMED: 27680029] - PubMed
Santibañez 2014 {published data only}
    1. Santibañez A, García J, Pashkova O, Colín O, Castellanos G, Sánchez AP, et al. Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study. Reproductive Biology and Endocrinology 2014;12:9. [DOI: 10.1186/1477-7827-12-9; PUBMED: 24476536] - DOI - PMC - PubMed
Singh 2014 {published data only}
    1. Singh R, Singh M. Intra‐uterine administration of human chorionic gonadotrophin (hCG) before embryo transfer in recurrent implantation failure (RIF) patients improves implantation and pregnancy rates in IVF‐ICSI cycles. Human Reproduction 2014;29(Suppl 1):i79.
Wirleitner 2015a {published data only}
    1. Wirleitner B, Schuff M, Vanderzwalmen P, Stecher A, Okhowat J, Hradecký L, et al. Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study. Reproductive Biology and Endocrinology 2015;13:70. [DOI: 10.1186/s12958-015-0069-1; PUBMED: 26141379] - DOI - PMC - PubMed
Wirleitner 2015b {published data only}
    1. Wirleitner B, Schuff M, Vanderzwalmen P, Stecher A, Hradecky L, Kohoutek T, et al. O‐182 ‐ the usefulness of intrauterine hCG administration prior to blastocyst transfer in IVF‐patients ≥38 years. Human Reproduction 2015;30(Suppl 1):i79‐i80. [DOI: 10.1093/humrep/30.Supplement_1.1] - DOI
Zarei 2014 {published data only}
    1. Zarei A, Parsanezhad ME, Younesi M, Alborzi S, Zolghadri J, Samsami A, et al. Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: a randomized clinical trial. Iranian Journal of Reproductive Medicine 2014;12:1‐6. [PUBMED: 24799855] - PMC - PubMed

References to studies excluded from this review

Dieamant 2016 {published data only}
    1. Dieamant F, Oliveira JBA, Petersen CG, Mauri AL, Vagnini LD, Renzi A, et al. Can the intrauterine infusion of hCG improve ART outcomes? Unsafe and conflicting results in meta‐analyses. Human Reproduction 2016;31(Suppl 1):i250. [DOI: 10.1093/humrep/31.Supplement_1.1] - DOI
Giuliani 2015 {published data only}
    1. Giuliani E, Olson M, Strug M, Young J, Shavell V, Dodds W, et al. Intrauterine hCG infusion affects the distribution of natural killer cells in the endometrium of fertile oocyte donors. Fertility and Sterility 2015;104:e149‐e150.
Huang 2017 {published data only}
    1. Huang P, Wei L, Li X, Qin A. Effects of intrauterine perfusion of human chorionic gonadotropin in women with different implantation failure numbers. American Journal of Reproductive Immunology 2017;79:e12809. [DOI: 10.1111/aji.12809; PUBMED: 29288552] - DOI - PubMed
Janati 2013 {published data only}
    1. Janati S, Dehghani Firouzabadi R, Mohseni F, Razi MH. Evaluation of effect of intrauterine human chorionic gonadotropin injection before embryo transfer in implantation and pregnancy rate in infertile patients and comparison with conventional embryo transfer in IVF/ICSI/ET cycles. Iranian Journal of Reproductive Medicine 2013;11:67‐8.
Jeong 2013 {published data only}
    1. Jeong HJ, Ryu MJ, Kim HM, Lee HS, Lee JH, Chung MK. Intrauterine injection of hCG before embryo transfer improves the clinical pregnancy rate and implantation rate in the patients with repeated implantation failure. Proceedings of the 5th IVI International Congress; 2013 Apr 4‐6; Seville, Spain. http://www.comtecmed.com/ivi/2013/Uploads/Editor/abstract_56.pdf 2013. [http://www.comtecmed.com/ivi/2013/Uploads/Editor/abstract_56.pdf]
Kanter 2017 {published data only}
    1. Kanter JR, Pollitzer C, Rao AS, Servy EJ, Massey J, Gavrilova‐Jordan L. Intrauterine injection of hCG to enhance embryo implantation. Fertility and Sterility 2017;108:e370–e371.
Li 2013 {published data only}
    1. Li T, Wang X, Yue C, Zhang J, Huang R, Liang X, et al. Intrauterine injection of human chorionic gonadotropin improves the pregnancy rates in in‐vitro fertilization‐embryo transfer cycles of repeated failures. Journal of Clinicians (Electronic Edition) 2013;7:3862‐5. [DOI: 10.3877/cma.j.issn.1674-0785.2013.09.0102] - DOI
Osman 2016 {published data only}
    1. Osman A, Pundir J, Elsherbini M, Dave S, El‐Toukhy T, Khalaf Y. The effect of intrauterine HCG injection on IVF outcome: a systematic review and meta‐analysis. Reproductive BioMedicine Online 2016;33:350‐9. [DOI: 10.1016/j.rbmo.2016.05.010; PUBMED: 27317131] - DOI - PubMed
Rebolloso 2013 {published data only}
    1. Rebolloso MM, Rosales De Leon JC, Galache Vega P, Santos‐Haliscak R, Diaz‐Spindola P, Gonzalez Vega O. Do intrauterine injection of human chorionic gonadotropin (hCG) before embryo transfer increases implantation and pregnancy rates in patients undergoing in vitro fertilization?. Fertility and Sterility 2013;100:S289. [DOI: 10.1016/j.fertnstert.2013.07.1082] - DOI
Riboldi 2013 {published data only}
    1. Riboldi M, Barros B, Piccolomini M, Alegretti JR, Motta ELA, Serafini PC. Does the intrauterine administration of rhCG before vitrified blastocysts transfer improves the potential of pregnancies when using blastocysts of inferior morphological grading?. Fertility and Sterility 2013;100:S289. [DOI: 10.1016/j.fertnstert.2013.07.1080] - DOI
Strug 2016 {published data only}
    1. Strug MR, Su R, Young JE, Dodds WG, Shavell VI, Díaz‐Gimeno P, et al. Intrauterine human chorionic gonadotropin infusion in oocyte donors promotes endometrial synchrony and induction of early decidual markers for stromal survival: a randomized clinical trial. Human Reproduction 2016;31:1552‐61. [DOI: 10.1093/humrep/dew080; PUBMED: 27122490] - DOI - PMC - PubMed
Volovsky 2016 {published data only}
    1. Volovsky M, Healey M, MacLachlan VB, Vollenhoven BJ. Intrauterine human chorionic gonadotropin (hCG) infusion prior to embryo transfer (ET) may be detrimental to pregnancy rate. Fertility and Sterility 2016;106:e52.
Ye 2015 {published data only}
    1. Ye H, Hu J, He W, Zhang Y, Li C. The efficacy of intrauterine injection of human chorionic gonadotropin before embryo transfer in assisted reproductive cycles: meta‐analysis. Journal of International Medical Research 2015;43:738‐46. [DOI: ; PUBMED: 26359294] - PubMed

References to studies awaiting assessment

Badehnoosh 2014 {published data only}
    1. Badehnoosh B, Mohammadzadeh A, Sadeghi M, Akhondi M, Kazemnejad S, Sadaei‐Jahromi N, et al. O‐27 ‐ the effects of intrauterine injection of human chorionic gonadotropin (hCG) before embryo transfer on the implantation rate in the intracytoplasmic sperm injection (ICSI) program. Iranian Journal of Reproductive Medicine 2014;12(Suppl 1):10‐11.
Bhat 2014 {published data only (unpublished sought but not used)}
    1. Bhat VV, Dutta I, Dutta DK, Gcitha MD. Outcome of intrauterine injection of human chorionic gonadotropin before embryo transfer in patients with previous IVF/ICSI failure: a randomized study. Journal of South Asian Federation of Obstetrics and Gynaecology 2014;6(1):15‐7. [DOI: 10.5005/jp-journals-10006-1259] - DOI

References to ongoing studies

IRCT2017041733486N1 {published data only}
    1. Evaluation effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on implantation rate and pregnancy rate in frozen cycles on IVF/ICSI. Ongoing study October 2017.
NCT02668965 {published data only}
    1. The effects of intrauterine infusion of hCG at the time of embryo transfer. Ongoing study December 2015.
NCT02825108 {published data only}
    1. Intrauterine injection of human chorionic gonadotropin injection (hCG) before embryo transfer on pregnancy outcomes in frozen embryo transfer cycles. Ongoing study January 2015.
NCT02870855 {published data only}
    1. Effect of intrauterine injection of hCG on pregnancy outcome in repeated implantation failure patients. Ongoing study July 2017.
NCT03238807 {published data only}
    1. Effect of intrauterine injection of hCG before ET on clinical outcomes in IVF/ICSI cycles. Ongoing study October 2017.

Additional references

Abou‐Setta 2014
    1. Abou‐Setta AM, Peters LR, D'Angelo A, Sallam HN, Hart RJ, Al‐Inany HG. Post‐embryo transfer interventions for assisted reproduction technology cycles. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD006567.pub3; PUBMED: 25157849] - DOI - PMC - PubMed
Akhtar 2013
    1. Akhtar MA, Sur S, Raine‐Fenning N, Jayaprakasan K, Thornton JG, Quenby S. Heparin for assisted reproduction. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD009452.pub2; PUBMED: 23955506] - DOI - PMC - PubMed
Bourdiec 2013
    1. Bourdiec A, Bédard D, Rao CV, Akoum A. Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine‐mediated effect on cell proliferation, migration and the release of angiogenic factors. American Journal of Reproductive Immunology 2013;70:127‐38. [DOI: 10.1111/aji.12080; PUBMED: 23351058] - DOI - PubMed
Brown 2010
    1. Brown J, Buckingham K, Abou‐Setta AM, Buckett W. Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006107.pub3; PUBMED: 20091584] - DOI - PubMed
Cole 2010
    1. Cole LA. Biological functions of hCG and hCG‐related molecules. Reproductive Biology and Endocrinology 2010;8:102. [DOI: 10.1186/1477-7827-8-102; PUBMED: 20735820] - DOI - PMC - PubMed
Craciunas 2014
    1. Craciunas L, Tsampras N, Fitzgerald C. Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta‐analysis of randomized controlled trials. Fertility and Sterility 2014;101:1302‐7. [DOI: 10.1016/j.fertnstert.2014.01.047; PUBMED: 24602754] - DOI - PubMed
Derks 2009
    1. Derks RS, Farquhar C, Mol BW, Buckingham K, Heineman MJ. Techniques for preparation prior to embryo transfer. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007682.pub2; PUBMED: 19821435] - DOI - PubMed
Diedrich 2007
    1. Diedrich K, Fauser BC, Devroey P, Griesinger G, Evian Annual Reproduction (EVAR) Workshop Group. The role of the endometrium and embryo in human implantation. Human Reproduction Update 2007;13:365‐77. [PUBMED: 17548368] - PubMed
GRADE 2013
    1. Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. The GRADE Working Group, 2013.
GRADEpro 2015 [Computer program]
    1. McMaster University. GRADEpro GDT: GRADEpro Guideline Development Tool. Hamilton (ON): McMaster University, 2015.
Higgins 2011
    1. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Kayisli 2003
    1. Kayisli UA, Selam B, Guzeloglu‐Kayisli O, Demir R, Arici A. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas‐Fas ligand system. Journal of Immunology 2003;171:2305‐13. [PUBMED: 12928375] - PubMed
Kupka 2014
    1. Kupka MS, Ferraretti AP, Mouzon J, Erb K, D'Hooghe T, Castilla JA, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE. Human Reproduction 2014;29:2099‐113. [DOI: 10.1093/humrep/deu175; PUBMED: 25069504] - DOI - PubMed
Licht 1998
    1. Licht P, Lösch A, Dittrich R, Neuwinger J, Siebzehnrübl E, Wildt L. Novel insights into human endometrial paracrinology and embryo‐maternal communication by intrauterine microdialysis. Human Reproduction Update 1998;4:532‐8. [PUBMED: 10027606] - PubMed
Mansour 1990
    1. Mansour R, Aboulghar M, Serour G. Dummy embryo transfer: a technique that minimizes the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilization. Fertility and Sterility 1990;54:678‐81. [PUBMED: 2209889] - PubMed
Nastri 2012
    1. Nastri CO, Gibreel A, Raine‐Fenning N, Maheshwari A, Ferriani RA, Bhattacharya S, et al. Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews 2012, Issue 7. [CENTRAL: CD009517; DOI: 10.1002/14651858.CD009517.pub2; PUBMED: 22786529] - DOI - PubMed
Racicot 2014
    1. Racicot KE, Wünsche V, Auerbach B, Aldo P, Silasi M, Mor G. Human chorionic gonadotropin enhances trophoblast‐epithelial interaction in an in vitro model of human implantation. Reproductive Sciences 2014;21:1274‐80. [DOI: 10.1177/1933719114522553; PUBMED: 24520082] - DOI - PMC - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schoolcraft 2001
    1. Schoolcraft WB, Surrey ES, Gardner DK. Embryo transfer: techniques and variables affecting success. Fertility and Sterility 2001;76:863‐70. [PUBMED: 11704102] - PubMed
Siristatidis 2016
    1. Siristatidis CS, Basios G, Pergialiotis V, Vogiatzi P. Aspirin for in vitro fertilisation. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD004832.pub4] - DOI - PMC - PubMed
Zegers‐Hochschild 2009
    1. Zegers‐Hochschild F, Adamson GD, Mouzon J, Ishihara O, Mansour R, Nygren K, et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Human Reproduction 2009;24:2683‐7. [DOI: 10.1093/humrep/dep343; PUBMED: 19801627] - DOI - PubMed

References to other published versions of this review

Craciunas 2015
    1. Craciunas L, Tsampras N, Coomarasamy A, Raine‐Fenning N. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD011537] - DOI
Craciunas 2016
    1. Craciunas L, Tsampras N, Coomarasamy A, Raine‐Fenning N. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD011537.pub2; PUBMED: 27195724] - DOI - PubMed

MeSH terms

Substances